| Pain management, controlled substances, and state medical board policy: a decade of change. | |
| | |
MedLine Citation:
|
PMID: 11844634 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Physicians' concerns about regulatory scrutiny and the possibility of unwarranted investigation by regulatory agencies negatively affect their prescribing of opioid analgesics to treat pain. Indeed, some state medical boards have rejected prescribing practices that are considered acceptable by today's standards. This article describes a ten-year program of research, education, and policy development implemented by the Pain & Policy Studies Group aimed at updating and clarifying state medical board policies on the use of opioid analgesics to treat pain, including cancer and chronic noncancer pain. Following surveys of medical board members and educational workshops, state medical board policies began an initial period of change, drawing on guidelines from other states, particularly in California. The next phase of policy development was marked by the introduction of Model Guidelines by the Federation of State Medical Boards of the U.S. The Model Guidelines address professional standards for the appropriate prescribing of opioid analgesics for pain management, as well as physicians' fears of regulatory scrutiny. Although most state medical boards have adopted regulations, guidelines, or policy statements relating to controlled substances and pain management, to date ten boards have adopted the Model Guidelines, while ten more have adopted the Model Guidelines in part. Further actions are recommended so that state medical boards can address inadequate pain management and physician concerns about regulatory scrutiny. |
| | |
Authors:
|
David E Joranson; Aaron M Gilson; June L Dahl; J David Haddox |
Related Documents
:
|
12674944 - Bullying and harassment in perioperative settings. 9121664 - Intravenous line diameter: is bigger really better? 1893554 - Factitious anisocoria and orthostatic hypotension. 10732394 - The comprehensive osteopathic medical licensing examination, comlex-usa: a new paradigm... 1585564 - Advantages and guidelines for using halothane. 10890244 - John langdon down: the man and the message. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Journal of pain and symptom management Volume: 23 ISSN: 0885-3924 ISO Abbreviation: J Pain Symptom Manage Publication Date: 2002 Feb |
Date Detail:
|
Created Date: 2002-02-14 Completed Date: 2002-03-20 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8605836 Medline TA: J Pain Symptom Manage Country: United States |
Other Details:
|
Languages: eng Pagination: 138-47 Citation Subset: IM |
Affiliation:
|
Pain & Policy Studies Group, Madison, WI 53711, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics, Opioid
/
standards*,
therapeutic use* Humans Pain / drug therapy* Policy Making Specialty Boards / standards* Time Factors United States |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chronic pain prevalence and analgesic prescribing in a general medical population.
Next Document: Methadone and fluconazole: respiratory depression by drug interaction.